H. Furukori

发表

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Body mass index and quality of life among outpatients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2013, BMC Psychiatry.

Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice.

K. Otani, A. Suzuki, S. Kaneko, 1999, International clinical psychopharmacology.

Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam

K. Otani, S. Kaneko, T. Kondo, 2000, Psychopharmacology.

Effect of Carbamazepine on the Single Oral Dose Pharmacokinetics of Alprazolam

K. Otani, S. Kaneko, T. Kondo, 1998, Neuropsychopharmacology.

The Effects of Ginkgo biloba Extracts on the Pharmacokinetics and Pharmacodynamics of Donepezil

N. Yasui-Furukori, S. Kaneko, T. Tateishi, 2004, Journal of clinical pharmacology.

Dose-Dependent Interaction of Paroxetine With Risperidone in Schizophrenic Patients

N. Yasui-Furukori, S. Kaneko, M. Saito, 2005, Journal of clinical psychopharmacology.

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2011, Annals of general psychiatry.

Prevalence of metabolic syndrome among patients with schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Nakaji, 2010, Schizophrenia Research.

Steady-State Pharmacokinetics of a New Antipsychotic Agent Perospirone and Its Active Metabolite, and Its Relationship with Prolactin Response

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2004, Therapeutic drug monitoring.

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan

Norio Sugawara, N. Yasui-Furukori, S. Tsuchimine, 2015, PloS one.

Effect of age and disease on bone mass in Japanese patients with schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2012, Annals of General Psychiatry.

Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite

K. Otani, A. Suzuki, S. Kaneko, 1998, Psychopharmacology.

Dietary patterns and schizophrenia: a comparison with healthy controls

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2015, Neuropsychiatric disease and treatment.

Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients

K. Otani, A. Suzuki, S. Kaneko, 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.

T. Kondo, K. Otani, A. Suzuki, 2001, Pharmacogenetics.

Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.

K. Otani, A. Suzuki, S. Kaneko, 2000, Therapeutic drug monitoring.

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff

Norio Sugawara, N. Yasui-Furukori, Kazuhiko Nakamura, 2018, Neuropsychiatric disease and treatment.

Effects of the CYP2D6*10 allele on the steady‐state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia

K. Otani, A. Suzuki, S. Kaneko, 1999, Clinical pharmacology and therapeutics.

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

Norio Sugawara, K. Shimoda, A. Fujii, 2021, Neuropsychiatric disease and treatment.

Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes

A. Suzuki, S. Kaneko, R. de Vries, 2002, Psychopharmacology.

Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients

A. Suzuki, S. Kaneko, M. Saito, 2010, Journal of psychopharmacology.

Prolactin response to nemonapride, a new antipsychotic drug, in schizophrenic patients

K. Otani, A. Suzuki, S. Kaneko, 1997 .

Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report

N. Yasui-Furukori, T. Kondo, K. Otani, 2001, European Archives of Psychiatry and Clinical Neuroscience.

Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia.

S. Kaneko, N. Yasui, K. Sugawara, 1999, Journal of Pharmaceutical and Biomedical Analysis.

No pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidol.

K. Otani, A. Suzuki, S. Kaneko, 1999, Therapeutic drug monitoring.

Dose-Dependent Effects of Adjunctive Treatment With Aripiprazole on Hyperprolactinemia Induced by Risperidone in Female Patients With Schizophrenia

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Journal of clinical psychopharmacology.

Therapeutic effects of bromperidol on the five dimensions of schizophrenic symptoms

K. Otani, A. Suzuki, S. Kaneko, 2002, Progress in Neuro-psychopharmacology and Biological Psychiatry.

Establishment of New Cloned Enzyme Donor Immunoassays (CEDIA®) for Haloperidol and Bromperidol

T. Someya, S. Kaneko, Y. Inoue, 2004, Therapeutic drug monitoring.

Poor Reliability of Therapeutic Drug Monitoring Data for Haloperidol and Bromperidol Using Enzyme Immunoassay

N. Yasui-Furukori, S. Kaneko, Y. Inoue, 2003, Therapeutic drug monitoring.

The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients

S. Kaneko, M. Saito, S. Tsuchimine, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients

Norio Sugawara, N. Yasui-Furukori, S. Kaneko, 2010, Human psychopharmacology.

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan

Norio Sugawara, S. Kaneko, Tetsu Tomita, 2014, Neuropsychiatric disease and treatment.

Attitudes toward placebo-controlled clinical trials among depressed patients in Japan.

Norio Sugawara, S. Tsuchimine, Koji Tsuruga, 2018, Journal of affective disorders.

Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidol

K. Otani, A. Suzuki, S. Kaneko, 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Interaction between carbamazepine and bromperidol

K. Otani, A. Suzuki, S. Kaneko, 1997, European Journal of Clinical Pharmacology.

Relationship between occupational stress and depression among psychiatric nurses in Japan

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2016, Archives of environmental & occupational health.

Characteristics of the tree‐drawing test in chronic schizophrenia

Manabu Saito, Norio Sugawara, S. Kaneko, 2010, Psychiatry and clinical neurosciences.

Relationship between single oral dose pharmacokinetics of alprazolam and triazolam

K. Otani, S. Kaneko, H. Tasaki, 1997, International clinical psychopharmacology.

Histamine H1-Receptor Antagonists, Promethazine and Homochlorcyclizine, Increase the Steady-State Plasma Concentrations of Haloperidol and Reduced Haloperidol

K. Otani, A. Suzuki, S. Kaneko, 2003, Therapeutic drug monitoring.

Effects of itraconazole on the steady-state plasma concentrations of haloperidol and its reduced metabolite in schizophrenic patients: in vivo evidence of the involvement of CYP3A4 for haloperidol metabolism.

K. Otani, A. Suzuki, S. Kaneko, 1999, Journal of clinical psychopharmacology.

Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients

K. Otani, S. Kaneko, Y. Inoue, 1999, Psychopharmacology.

Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia

Norio Sugawara, S. Kaneko, M. Saito, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Dietary patterns are associated with obesity in Japanese patients with schizophrenia

Manabu Saito, Norio Sugawara, N. Yasui-Furukori, 2014, BMC Psychiatry.

Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam

K. Otani, S. Kaneko, Tadashi Ohkubo, 1998, Psychopharmacology.

Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2009, The Journal of clinical psychiatry.

A crossover study on the glucose metabolism between treatment with olanzapine and risperidone in schizophrenic patients.

N. Yasui-Furukori, S. Kaneko, M. Saito, 2010, Experimental and clinical psychopharmacology.

Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years

Norio Sugawara, K. Shimoda, Kensuke Miyazaki, 2023, Neuropsychiatric disease and treatment.

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan

Norio Sugawara, Kazuyo Kitaoka, A. Fujii, 2017, Neuropsychiatric disease and treatment.

Comparing the influences of age and disease on distortion in the clock drawing test in Japanese patients with schizophrenia.

Norio Sugawara, S. Nakaji, S. Kaneko, 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Prolactin response to nemonapride, a new antipsychotic drug, in schizophrenic patients

K. Otani, A. Suzuki, S. Kaneko, 1997 .

hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Norio Sugawara, Masamichi Ishioka, H. Furukori, 2015 .

Relationship between occupational stress and depression among psychiatric nurses in Japan

Norio Sugawara, Kazuhiko Nakamura, A. Fujii, 2016, Archives of environmental & occupational health.